Kyntra Bio, Inc.
General ticker "KYNB" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $29.0M (TTM average)
Kyntra Bio, Inc. does not follow the US Stock Market performance with the rate: -12.0%.
Estimated limits based on current volatility of 5.6%: low 3.69$, high 4.13$
Factors to consider:
- Current price 25.4% below estimated low
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [5.23$, 17.31$]
- 2026-12-31 to 2027-12-31 estimated range: [4.51$, 14.84$]
Short-term KYNB quotes
Long-term KYNB plot with estimates
Financial data
| YTD | 2025-12-31 |
|---|---|
| Operating Revenue | $6.44MM |
| Operating Expenses | $52.34MM |
| Operating Income | $-45.90MM |
| Non-Operating Income | $-12.40MM |
| Interest Expense | $8.76MM |
| R&D Expense | $23.52MM |
| Income(Loss) | $-58.29MM |
| Taxes | $-0.09MM |
| Net Income(Loss)* | $183.45MM |
| Stockholders Equity | $-30.04MM |
| Inventory | $3.74MM |
| Assets | $119.59MM |
| Operating Cash Flow | $-4.77MM |
| Capital expenditure | $0.04MM |
| Investing Cash Flow | $35.42MM |
| Financing Cash Flow | $-86.03MM |
| Earnings Per Share** | $45.38 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.